NCT04047173View on ClinicalTrials.gov

RFA Versus SBRT for Recurrent Small HCC

PHASE3CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

stereotactic body radiotherapy (SBRT)

Radiotherapy dose is 36-54 Gy, irradiated in 3 times, every other day, completed within 1 week.

PROCEDURE

Radiofrequency ablation (RFA)

RFA with a safe margin, RFA again if residual, no more than 2 times.

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT04047173 - RFA Versus SBRT for Recurrent Small HCC | Biotech Hunter | Biotech Hunter